241 filings
Page 3 of 13
8-K
uwma2j
1 Nov 22
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2022 Financial Results
4:05pm
8-K
9iqmi3kqw9i
27 Oct 22
CRISPR Therapeutics Announces Planned Transition of Chief Operating Officer
8:36am
8-K
z9lsemv8 4yy3
27 Sep 22
Vertex and CRISPR Therapeutics Announce Global exa-cel Regulatory Submissions for Sickle Cell Disease and Beta Thalassemia in 2022
7:48am
S-8
qoalme40dl vziennh
8 Aug 22
Registration of securities for employees
4:06pm
8-K
fk7zj272 osyh
8 Aug 22
CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2022 Financial Results
8:05am
CORRESP
7q62 4h2zl
23 Jun 22
Correspondence with SEC
12:00am
8-K
nzmuakpd ckzxqn7di
21 Jun 22
Other Events
5:05pm
8-K
ub3qbdug0ro
13 Jun 22
Departure of Directors or Certain Officers
4:58pm
8-K
hmf7 btly9dn3i
13 Jun 22
Regulation FD Disclosure
8:02am
UPLOAD
zex iwza0
13 Jun 22
Letter from SEC
12:00am
8-K
m5bbvfe mdlmc
16 May 22
CRISPR Therapeutics Announces the Appointment of Phuong Khanh Morrow, M.D., FACP, as Chief Medical Officer
4:14pm
8-K
xmr887ac16
12 May 22
Regulation FD Disclosure
4:05pm
8-K
e14wrjdp0m koo0j
9 May 22
Results of Operations and Financial Condition
4:06pm
DEFA14A
6u81dofa 05ndghjddie
25 Apr 22
Additional proxy soliciting materials
4:27pm